BTLA antibody (C-Term)
Quick Overview for BTLA antibody (C-Term) (ABIN2789021)
Target
See all BTLA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- BTLA Antibody - C-terminal region
-
Sequence
- SRPWLLYSLL PLGGLPLLIT TCFCLFCCLR RHQGKQNELS DTAGREINLV
-
Predicted Reactivity
- Horse: 79%, Human: 100%
-
Characteristics
- This is a rabbit polyclonal antibody against BTLA. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP62109-100UG
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- prevent freeze-thaw cycles
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Alternative Name
- BTLA
-
Background
-
Background Information: This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.
Gene Name: B and T lymphocyte associated
Alternative Symbols: BTLA1, CD272
Protein Name: B- and T-lymphocyte attenuator
-
Molecular Weight
- 32kDa
-
Gene ID
- 151888
-
NCBI Accession
- NP_861445
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-